Martin Vazquez - Nov 11, 2022 Form 4 Insider Report for Outset Medical, Inc. (OM)

Role
Chief Operating Officer
Signature
By: John L Brottem For: Martin Vazquez
Stock symbol
OM
Transactions as of
Nov 11, 2022
Transactions value $
-$241,800
Form type
4
Date filed
11/14/2022, 06:59 PM
Previous filing
Aug 16, 2022
Next filing
Nov 17, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OM Common Stock Options Exercise $19.4K +5K +10.09% $3.88* 54.6K Nov 11, 2022 Direct F1
transaction OM Common Stock Sale -$100K -5K -9.17% $20.00 49.6K Nov 11, 2022 Direct F2
transaction OM Common Stock Options Exercise $19.4K +5K +10.09% $3.88* 54.6K Nov 11, 2022 Direct
transaction OM Common Stock Sale -$100K -5K -9.17% $20.00 49.6K Nov 11, 2022 Direct F2
transaction OM Common Stock Options Exercise $18K +4.63K +9.34% $3.88* 54.2K Nov 11, 2022 Direct
transaction OM Common Stock Sale -$92.6K -4.63K -8.55% $20.00 49.6K Nov 11, 2022 Direct F2
transaction OM Common Stock Options Exercise $1.44K +370 +0.75% $3.88* 49.9K Nov 11, 2022 Direct
transaction OM Common Stock Sale -$7.4K -370 -0.74% $20.00 49.6K Nov 11, 2022 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OM Performance Options (right to buy) Options Exercise $0 -5K -5.1% $0.00 93K Nov 11, 2022 Common Stock 5K $3.88 Direct F3
transaction OM Performance Options (right to buy) Options Exercise $0 -5K -5.38% $0.00 88K Nov 11, 2022 Common Stock 5K $3.88 Direct F3
transaction OM Performance Options (right to buy) Options Exercise $0 -4.63K -5.26% $0.00 83.4K Nov 11, 2022 Common Stock 4.63K $3.88 Direct F3
transaction OM Performance Options (right to buy) Options Exercise $0 -370 -0.44% $0.00 83K Nov 11, 2022 Common Stock 370 $3.88 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 573 shares of Common Stock acquired pursuant to the Outset Medical, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the purchase period of March 1, 2022 to August 31, 2022. This transaction is exempt from Rule 16b-3(c).
F2 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2022.
F3 In March 2021, following the expiration of the lock-up period in connection with our initial public offering, the applicable performance and market-based vesting conditions were met and the shares underlying this stock option award became fully vested.